Mitochondrial Structure and Function in Human Heart Failure
Circulation Research · 05.07.2024 · 135 (2) · 372-396
DOI: 10.1161/circresaha.124.323800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 05.07.2024. Verfasst von Antentor Hinton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics (A.H., K.N.), Vanderbilt University Medical Center, Nashville. Hauptthemen laut MEDLINE: Heart Failure, Mitochondria, Heart. Die Arbeit wurde bisher 245-mal zitiert (Crossref) und nennt 303 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Despite clinical and scientific advancements, heart failure is the major cause of morbidity and mortality worldwide. Both mitochondrial dysfunction and inflammation contribute to the development and progression of heart failure. Although inflammation is crucial to reparative healing following acute cardiomyocyte injury, chronic inflammation damages the heart, impairs function, and decreases cardiac output. Mitochondria, which comprise one third of cardiomyocyte volume, may prove a potential therapeutic target for heart failure. Known primarily for energy production, mitochondria are also involved in other processes including calcium homeostasis and the regulation of cellular apoptosis. Mitochondrial function is closely related to morphology, which alters through mitochondrial dynamics, thus ensuring that the energy needs of the cell are met. However, in heart failure, changes in substrate use lead to mitochondrial dysfunction and impaired myocyte function. This review discusses mitochondrial and cristae dynamics, including the role of the mitochondria contact site and cristae organizing system complex in mitochondrial ultrastructure changes. Additionally, this review covers the role of mitochondria-endoplasmic reticulum contact sites, mitochondrial communication via nanotunnels, and altered metabolite production during heart failure. We highlight these often-neglected factors and promising clinical mitochondrial targets for heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Physiology and Biophysics (A.H., K.N.), Vanderbilt University Medical Center, Nashville.
- Department of Physiology, Mitochondrial Phospholipid Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland (S.M.C., N.S.).
- Department of Medicine, Division of Clinical Pharmacology (C.N.W., A.K.), Vanderbilt University Medical Center, Nashville.
- Vanderbilt Center for Immunobiology (A.K.).
- Vanderbilt Institute for Infection, Immunology and Inflammation (A.K.).
- Vanderbilt Institute for Global Health (A.K.).
ORCID-Profile: Antentor Hinton, Steven M Claypool, Kit Neikirk, Annet Kirabo, Clintoria R Williams
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Hinton, A., Claypool, S. M., Neikirk, K., Senoo, N., Wanjalla, C. N., Kirabo, A., & Williams, C. R. (2024). Mitochondrial Structure and Function in Human Heart Failure. Circulation Research, 135(2), 372-396. https://doi.org/10.1161/circresaha.124.323800
Vancouver
Hinton A, Claypool SM, Neikirk K, Senoo N, Wanjalla CN, Kirabo A, et al. Mitochondrial Structure and Function in Human Heart Failure. Circulation Research. 2024;135(2):372-396. doi:10.1161/circresaha.124.323800
BibTeX
@article{Hinton2024,
author = {Hinton, Antentor and Claypool, Steven M and Neikirk, Kit and Senoo, Nanami and Wanjalla, Celestine N and Kirabo, Annet and Williams, Clintoria R},
title = {Mitochondrial Structure and Function in Human Heart Failure},
journal = {Circulation Research},
year = {2024},
volume = {135},
number = {2},
pages = {372--396},
doi = {10.1161/circresaha.124.323800}
}
EUVIMED